(3) Our study is the first to demonstrate, both in vitro and in vivo, that berberine suppressed LUAD cell proliferation and tumor growth by targeting COX5B, offering a potential therapeutic target and strategy for clinical treatment. This evidence concerns the gene COX5B and neoplasm.